Anlotinib hydrochloride capsule

Anlotinib hydrochloride · Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for Anlotinib hydrochloride capsule, covering 2020-05-13 to 2026-01-30. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy as First-line Treatment in Subjects With RAS/BRAF Wild Metastatic Colorectal Cancer [Phase 3]

See pricing